2011
DOI: 10.5114/pg.2011.25376
|View full text |Cite
|
Sign up to set email alerts
|

Pathomechanism of insulin resistance in chronic hepatitis C

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 48 publications
0
1
0
Order By: Relevance
“…Chronic hepatitis C (CHC), because of concomitant insulin resistance (IR) [6,7], high prevalence of steatosis [8,9], increased prevalence of impaired glucose tolerance and/or type 2 diabetes mellitus (T2DM) [10,11,12] and changes in lipid metabolism [13], has been considered not only as a viral disease, but also as a metabolic liver disease. Moreover, IR is a strong predictor of poor response to antiviral therapy, alongside advanced hepatic steatosis and fibrosis [6,14].…”
Section: Introductionmentioning
confidence: 99%
“…Chronic hepatitis C (CHC), because of concomitant insulin resistance (IR) [6,7], high prevalence of steatosis [8,9], increased prevalence of impaired glucose tolerance and/or type 2 diabetes mellitus (T2DM) [10,11,12] and changes in lipid metabolism [13], has been considered not only as a viral disease, but also as a metabolic liver disease. Moreover, IR is a strong predictor of poor response to antiviral therapy, alongside advanced hepatic steatosis and fibrosis [6,14].…”
Section: Introductionmentioning
confidence: 99%